Anxiolytic effects of dopamine receptor ligands: I. involvement of dopamine autoreceptors
- 1 January 1998
- journal article
- Published by Elsevier in Life Sciences
- Vol. 62 (7) , 649-663
- https://doi.org/10.1016/s0024-3205(97)01160-0
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- BuspironeCNS Drugs, 1997
- Modulation of plus-maze behaviour in mice by the preferential D3-receptor agonist 7-OH-DPATPharmacology Biochemistry and Behavior, 1996
- D3 and D2 dopamine receptors: Visualization of cellular expression patterns in motor and limbic structuresSynapse, 1995
- Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Characteristics of stably expressed human dopamine D1a and D1b receptors: Atypical behavior of the dopamine D1b receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Substituted 3-phenylpiperidines: new centrally acting dopamine autoreceptor antagonistsJournal of Medicinal Chemistry, 1993
- The dopamine D3-receptor: A postsynaptic receptor inhibitory on rat locomotor activityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- Aporphines. 34. (-)-2,10,11-Trihydroxy-N-n-propylnoraporphine, a novel dopaminergic aporphine alkaloid with anticonvulsant activityJournal of Medicinal Chemistry, 1981